Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC-APCC Vaccine in Non-Metastatic Androgen Independent Prostate Cancer
NCT00814892Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Jan 2009
- Primary completion
- Dec 2009
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of DC-APCC in prostate carcinoma, sponsored by Mayo Clinic. Started Jan 2009; status: terminated.
02
Drugs
DC-APCC
03
Conditions
prostate carcinoma
Beyond the preview
Go deeper on NCT00814892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814892.